Honz Pharmaceutical Co., Ltd. (SHE:300086)

China flag China · Delayed Price · Currency is CNY
7.40
+0.18 (2.49%)
Apr 30, 2026, 3:04 PM CST
61.22%
Market Cap 3.37B
Revenue (ttm) 466.12M
Net Income (ttm) -230.14M
Shares Out 455.12M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,661,700
Average Volume 39,518,650
Open 7.05
Previous Close 7.22
Day's Range 7.05 - 7.49
52-Week Range 4.48 - 15.19
Beta 0.50
RSI 42.64
Earnings Date Apr 29, 2026

About Honz Pharmaceutical

Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China. The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks. It markets its products through a network of agents and sales terminals. Honz Pharmaceutical Co., Ltd. was formerly known as HaiNan Honz Pharmaceu... [Read more]

Sector Healthcare
Founded 1993
Employees 659
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300086
Full Company Profile

Financial Performance

In 2025, Honz Pharmaceutical's revenue was 466.12 million, a decrease of -1.42% compared to the previous year's 472.82 million. Losses were -230.14 million, 6.44% more than in 2024.

Financial Statements

News

There is no news available yet.